Simple Summary Invasive lobular breast cancer (ILC) is a special type of breast cancer (BC)
that was first described in 1941. The diagnosis of ILC is made by microscopy of tumor …

Background: Screening clinical breast examination (CBE) is controversial; the use of CBE is
declining not only as a screening tool, but also as a diagnostic tool. In the present study, we …

Atypical hyperplasia and lobular carcinoma in situ are rare proliferative breast lesions,
growing inside ducts and terminal ducto-lobular units. They represent a marker of increased …

OBJECTIVE. The purpose of this article is to determine the upgrade rate to ductal carcinoma
in situ (DCIS) or invasive carcinoma at excision at the same site after percutaneous breast …

The distinction between benign and malignant papilloma of the breast through
percutaneous needle biopsy can be difficult because of limited samples; the …

Background Management recommendations for lobular neoplasia (LN) including lobular
carcinoma-in-situ (LCIS) and atypical lobular hyperplasia (ALH) diagnosed in core biopsies …

Objectives To investigate the radiological features, diagnosis and management of screen-
detected lobular neoplasia (LN) of the breast. Materials and methods 392 women with pure …

Objectives To evaluate the underestimation rate and clinical relevance of lobular neoplasia
in vacuum-assisted breast biopsy (VABB). Methods A total of 161 cases of LN were retrieved …

Background Biopsy-proven breast lesions such as atypical ductal hyperplasia (ADH) or
atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS) and flat epithelial atypia …

In this opinion piece, I suggest that we breast imagers modify our initial interpretations and
our downstream recommendations for screening mammograms, thereby reducing recall …